• Non ci sono risultati.

AIOM

N/A
N/A
Protected

Academic year: 2022

Condividi "AIOM"

Copied!
23
0
0

Testo completo

(1)

3rd AIOM National Course for Medical and Scientific Journalists

Reggio Emilia, June 30rd, July 1st, 2017

«Cancer Prevention and access to the new drugs: the point of view of AIOM Press Office»

Mauro Boldrini, journalist, AIOM Press Office

(2)

AIOM is strongly committed to preventing cancer through

Awareness campaigns for primary prevention (Festival della prevenzione e innovazione, Non fare autogol, ecc…)

Cancer prevention - 1

(3)

Booklets (Meglio smettere 2.0, In team più forti contro il cancro, Giochiamo d’anticipo contro il cancro, ecc…)

Cancer prevention - 2

(4)

Books

100 domande 100 risposte

about immunotheray and chemotherapy

Si può vincere

stories from patients who defeated cancer

Cancer prevention - 3

(5)

Cancer prevention - 4

Media coverage 2016 ESMO Meeting, Copenhagen

(6)

Cancer prevention - 5

Media coverage 2017 ASCO Meeting, Chicago

(7)

A road show in 16 Italian cities where medical oncologists met the citizens to explain the rule of prevention, the

importance of screenings, and the impact of the new

weapons against cancer to prolong survival as well as a good quality of life.

Festival of Prevention and Innovation in Oncology - 1

(8)

Round tables, meetings with students, health walks and entertainment shows were organized at each step of the tour

Booklets were distributed and surveys collected from the citizens

NGOs were present with Info Points to offer their support

Testimonial were invited to strengthen the message

Festival of Prevention and Innovation in Oncology - 2

(9)

196.000 people reached

123.000 booklets distributed

51.000 surveys collected

83 round tables and conferences

87 meetings with students

6 health walks

9 entertainment shows

904 posts on social media

200 articles on newspapers, online newspapers, radio,tv

Festival of Prevention and Innovation in Oncology – 3

Figures

(10)

Festival of Prevention and Innovation in Oncology - 4

(11)

Festival of Prevention and Innovation in Oncology - 5

(12)

• Awareness campaign targeting italian teenagers to highlight cancer main risk factors

With the partecipation of famous footballers and coaches who met the students together with the oncologists

Non fare autogol

(13)

Non fare autogol - Testimonials

(14)

Non fare autogol – Press clippings

(15)

Web apps - 1

In collaboration with Corriere della Sera newspaper, 7 apps dedicated to specific pathologies:

• Lung

• Breast

• Stomach

• Melanoma

• Pancreas

• Ovary

• Prostate

(16)

Web apps - 2

The user learn how to detect and prevent the risks associated with a specific cancer, through an interactive and multimedia path which provides simple questions related to a specific disease

(17)

Oncoline

An initiative in collaboration with Repubblica newspaper

An oncology project from patients’ side

A multimedia platform developed in April 2016 that goes:

online, with a specific website

on paper, with supplemental information on Repubblica Salute

in the community (territory), with public meetings involving Istitutions, doctors and patients

(18)

Oncoline interviews

2017 ASCO Meeting, Chicago

(19)

Social media

(20)

Access to the new drugs

Oncology Fund

A Campaign that addressed Italian Health Institutions claiming an Oncology Fund for innovating medicines

The promotion was made through the diffusion of a spot with the AIOM President Carmine Pinto on social media and national broadcasting TV

(21)

Oncology Fund

Press conferences

Rome 2015, October 23rd AIOM National Congress

Milan 2015, December 17th

Milan 2016, March 9th

Rome 2016, April 12th Senior Italia Federanziani Meeting

Chicago, IL, USA 2016, June 3rd ASCO Congress

Copenhagen Denmark 2016, October 8th ESMO Congress

Rome 2016, October 28th AIOM Congress

(22)

Access to the new drugs

Oncology Fund – Press clippings

(23)

Thank you!

Riferimenti

Documenti correlati

L’iniziativa promossa da Fondazione AIOM in collaborazione con i gruppi di lavoro Linee Guida AIOM a partire dal 2015, è volta a contribuire alla diffusione di

oncologica, e può essere integrata nei programmi di cure simultanee o anche esclusivamente palliative, sulla base di una valutazione personalizzata, delle possibili implicazioni

In attesa della decisione delle autorità regolatorie cosa dobbiamo fare oggi in. un

Alla luce dei risultati dello studio FLAURA di I linea e dello studio AURA 3 di II linea quale sarà la posizione di osimertinib nella sequenza terapeutica dei pazienti

Possibile ruolo degli inibitori delle cicline nella terapia neoadiuvante?.. Grazie per

Malattia HER 2 + a basso rischio: è possibile deintensificare il trattamento adiuvante.  depotenziare chemioterapia (regimi

L’Istituto Superiore di Sanità pubblica nel proprio sito internet le linee guida e gli aggiornamenti delle stesse indicati dal SNLG, previa verifica della conformità della

Dobbiamo continuare la pubblicazione, su riviste scientifiche, delle Linee Guida AIOM, come:. •Sinossi